Cell-free DNA screening in twin pregnancies
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cell-free DNA (cfDNA) screening for fetal aneuploidies is clinically available and exhibits better performance than conventional serum screening tests. However, data on the clinical performance of cfDNA screening in twin pregnancies are limited. In this review, we summarized the clinical performance and evaluated the feasibility of cfDNA screening in twin pregnancies based on recent studies and recommendations. The performance of cfDNA screening for trisomy 21 in twin pregnancies is similar to that in singleton pregnancies. Specifically, cfDNA screening has a higher detection rate and lower false-positive rate compared with conventional serum screening. Consequently, recent international guidelines from several academic communities have recommended that cfDNA screening for aneuploidy in twin pregnancies could be considered. Moreover, twin pregnancies can present with specific conditions, such as different zygosities and vanishing twins; therefore, individualized counseling and management are required. Further clinical studies with more twin pregnancies are required for a more accurate analysis.
Abstract
Cell-free DNA (cfDNA) screening for fetal aneuploidies is clinically available and exhibits better performance than conventional serum screening tests. However, data on the clinical performance of cfDNA screening in twin pregnancies are limited. In this review, we summarized the clinical performance and evaluated the feasibility of cfDNA screening in twin pregnancies based on recent studies and recommendations. The performance of cfDNA screening for trisomy 21 in twin pregnancies is similar to that in singleton pregnancies. Specifically, cfDNA screening has a higher detection rate and lower false-positive rate compared with conventional serum screening. Consequently, recent international guidelines from several academic communities have recommended that cfDNA screening for aneuploidy in twin pregnancies could be considered. Moreover, twin pregnancies can present with specific conditions, such as different zygosities and vanishing twins; therefore, individualized counseling and management are required. Further clinical studies with more twin pregnancies are required for a more accurate analysis.
참고문헌 (55)
- Gil MM, "Analysis of cell-free DNA in maternal blood in screening for aneuploidies : meta-analysis", Fetal Diagn Ther, 35, pp.156~173 (2014)
- Porreco RP, "Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA", Am J Obstet Gynecol, 211, pp.365~ (2014)
- Norton ME, "Cell-free DNA analysis for noninvasive examination of trisomy", N Engl J Med, 372, pp.1589~1597 (2015)
- Bai T, "Performance of noninvasive prenatal screening in twin pregnancies : a retrospective study of 5469 twin pregnancies", J Matern Fetal Neonatal Med, 35, pp.5999~6007 (2022)
- Jee J, "Pregnancy outcomes in twin pregnancies over 10 years", Obstet Gynecol Sci, 66, pp.20~25 (2022)
- Martin JA, "Three decades of twin births in the United States, 1980-2009", NCHS Data Brief, (80), pp.1~8 (2012)
- "Birth statics" (2022)[URL]
- Vink J, "Amniocentesis in twin pregnancies : a systematic review of the literature", Prenat Diagn, 32, pp.409~416 (2012)
- Hansen M, "Assisted reproductive technology and birth defects : a systematic review and meta-analysis", Hum Reprod Update, 19, pp.330~353 (2013)
- Agarwal K, "Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies : a systematic review", Ultrasound Obstet Gynecol, 40, pp.128~134 (2012)
- Prats P, "Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers : a meta-analysis", Prenat Diagn, 34, pp.1077~1083 (2014)
- Garchet-Beaudron A, "Second-trimester Down syndrome maternal serum marker screening : a prospective study of 11 040twin pregnancies", Prenat Diagn, 28, pp.1105~1109 (2008)
- Spencer K, "Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic : a review of three years experience", BJOG, 110, pp.276~280 (2003)
- Khalil A, "Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test : a prospective multicenter study", Am J Obstet Gynecol, 225, pp.79~ (2021)
- Ashoor G, "Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation : relation to maternal and fetal characteristics", Ultrasound Obstet Gynecol, 41, pp.26~32 (2013)
- Yaron Y, "The implications of non-invasive prenatal testing failures : a review of an under-discussed phenomenon", Prenat Diagn, 36, pp.391~396 (2016)
- Sarno L, "Prospective first-trimester screening for trisomies by cellfree DNA testing of maternal blood in twin pregnancy", Ultrasound Obstet Gynecol, 47, pp.705~711 (2016)
- Canick JA, "DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations", Prenat Diagn, 32, pp.730~734 (2012)
- Hedriana H, "Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening", Prenat Diagn, 40, pp.179~184 (2020)
- Struble CA, "Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis", Fetal Diagn Ther, 35, pp.199~203 (2014)
- Benn P, "Non-invasive prenatal testing in the management of twin pregnancies", Prenat Diagn, 41, pp.1233~1240 (2021)
- Norwitz ER, "Validation of a single-nucleotide polymorphism-based non-invasive prenatal test in twin gestations : determination of zygosity, individual fetal sex, and fetal aneuploidy", J Clin Med, 8, pp.937~ (2019)
- Qu JZ, "Noninvasive prenatal determination of twin zygosity by maternal plasma DNA analysis", Clin Chem, 59, pp.427~435 (2013)
- Benn P, "Non-invasive prenatal testing for aneuploidy : current status and future prospects", Ultrasound Obstet Gynecol, 42, pp.15~33 (2013)
- Lau TK, "Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies", J Matern Fetal Neonatal Med, 26, pp.434~437 (2013)
- Huang X, "Noninvasive prenatal testing of trisomies 21 and 18by massively parallel sequencing of maternal plasma DNA in twin pregnancies", Prenat Diagn, 34, pp.335~340 (2014)
- Le Conte G, "Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18and 13 in twin pregnancy", Ultrasound Obstet Gynecol, 52, pp.318~324 (2018)
- Yang J, "Performance of non-invasive prenatal testing for trisomies 21 and 18 in twin pregnancies", Mol Cytogenet, 11, pp.47~ (2018)
- Gil MM, "Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy : update of the fetal medicine foundation results and meta-analysis", Ultrasound Obstet Gynecol, 53, pp.734~742 (2019)
- Yu W, "Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies", Expert Rev Mol Diagn, 19, pp.189~196 (2019)
- Garshasbi M, "Clinical application of cell-free DNA sequencing-based noninvasive prenatal testing for trisomies 21, 18, 13 and sex chromosome aneuploidy in a mixed-risk population in Iran", Fetal Diagn Ther, 47, pp.220~227 (2020)
- Motevasselian M, "Non-invasive prenatal test to screen common trisomies in twin pregnancies", Mol Cytogenet, 13, pp.5~ (2020)
- Chibuk J, "Cell-free DNA screening in twin pregnancies : a more accurate and reliable screening tool", Prenat Diagn, 40, pp.1321~1329 (2020)
- Judah H, "Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy : updated cohort study at 10-14 weeks and meta-analysis", Ultrasound Obstet Gynecol, 58, pp.178~189 (2021)
- Gil MM, "Analysis of cell-free DNA in maternal blood in screening for aneuploidies : updated meta-analysis", Ultrasound Obstet Gynecol, 50, pp.302~314 (2017)
- Liao H, "Performance of non-invasive prenatal screening for fetal aneuploidy in twin pregnancies : a meta-analysis", Prenat Diagn, 37, pp.874~882 (2017)
- Warsof SL, "Overview of the impact of noninvasive prenatal testing on diagnostic procedures", Prenat Diagn, 35, pp.972~979 (2015)
- Gregg AR, "Noninvasive prenatal screening for fetal aneuploidy, 2016 update : a position statement of the American College of Medical Genetics and Genomics", Genet Med, 18, pp.1056~1065 (2016)
- Fosler L, "Aneuploidy screening by non-invasive prenatal testing in twin pregnancy", Ultrasound Obstet Gynecol, 49, pp.470~477 (2017)
- American College of Obstetricians and Gynecologists’Committee on Practice Bulletins—Obstetrics, "Screening for fetal chromosomal abnormalities : ACOG practice bulletin, number 226", Obstet Gynecol, 136, pp.e48~e69 (2020)
- Palomaki GE, "International Society for Prenatal Diagnosis position statement : cell free(cf)DNA screening for Down syndrome in multiple pregnancies", Prenat Diagn, 41, pp.1222~1232 (2021)
- Dungan JS, "Noninvasive prenatal screening(NIPS)for fetal chromosome abnormalities in a general-risk population : an evidence-based clinical guideline of the American College of Medical Genetics and Genomics(ACMG)", Genet Med, 25, pp.100336~ (2023)
- "Management of monochorionic twin pregnancy: greentop guideline no. 51", BJOG, 124, pp.e1~e45 (2017)
- Bevilacqua E, "Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies", Ultrasound Obstet Gynecol, 45, pp.61~66 (2015)
- Galeva S, "First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies : factors affecting test failure", Ultrasound Obstet Gynecol, 53, pp.804~809 (2019)
- del Mar Gil M, "Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies", Fetal Diagn Ther, 35, pp.204~211 (2014)
- Haghiac M, "Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women", Obesity(Silver Spring), 20, pp.2213~2219 (2012)
- Qiao L, "Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing", Am J Obstet Gynecol, 221, pp.345~ (2019)
- Evans MI, "Efficacy of second-trimester selective termination for fetal abnormalities : international collaborative experience among the world’s largest centers", Am J Obstet Gynecol, 171, pp.90~94 (1994)
- Kleinfinger P, "Noninvasive prenatal screening for trisomy 21 in patients with a vanishing twin", Genes(Basel), 13, pp.2027~ (2022)
- Márton V, "Prevalences and pregnancy outcome of vanishing twin pregnancies achieved by in vitro fertilization versus natural conception", Fertil Steril, 106, pp.1399~1406 (2016)
- Curnow KJ, "Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphismbased noninvasive prenatal test", Am J Obstet Gynecol, 212, pp.79~ (2015)
- Balaguer N, "Should vanishing twin pregnancies be systematically excluded from cell-free fetal DNA testing?", Prenat Diagn, 41, pp.1241~1248 (2021)
- Lee DR, "The effect of a vanishing twin on first-and second-trimester maternal serum markers and ultrasound screening for aneuploidy", Obstet Gynecol Sci, 66, pp.477~483 (2023)
- Audibert F, "No. 262-prenatal screening for and diagnosis of aneuploidy in twin pregnancies", J Obstet Gynaecol Canada, 39, pp.e347~e361 (2017)
